Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-21

FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for torsemide, granting approval of a generic torsemide product under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torsemide (torsemide)

Snippet

SUPPL AP for TORSEMIDE (TORSEMIDE)